Medium chain acyl CoA dehydrogenase (MCAD Deficiency)
Indications for
Molecular Testing
•Cardiac or skeletal myopathy
•Fasting hypoglycemia (hypoketotic)
•Reye-Like syndrome
•Family history of sudden,
unexplained infant death
Direct
Mutation Testing for MCAD Deficiency
Screening utilizes
polymerase chain reaction (PCR) and RFLP for detection of a point mutation
(A985G) in exon 11 of the medium chain acyl-CoA dehydrogenase (MCAD)
gene. The base pair change creates a new recognition site for the restriction
enzyme Nco I.